Home › Therapeutic areas › Oncology › Prostate Cancer
Prostate Cancer (7 companies)
Companies with an active program in Prostate Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | Oncology | 1 | Phase 1 | 9 |
| ARVN | ARVINAS, INC. | NeurologyOncology Rare | 2 | Approved | 15 |
| BCTX | BriaCell Therapeutics Corp. | Oncology | 1 | Phase 3 | 8 |
| IBRX | ImmunityBio, Inc. | Infectious DiseaseOncology | 1 | Approved | 17 |
| JANX | Janux Therapeutics, Inc. | Oncology | 1 | Phase 1 | 3 |
| GLUE | Monte Rosa Therapeutics, Inc. | CardiovascularDermatologyMetabolicOncology Rare | 1 | Phase 1 | 8 |
| VIR | Vir Biotechnology, Inc. | Infectious DiseaseOncology Rare | 2 | Phase 3 | 10 |
No companies match.